Compounds > fludarabine

fludarabine and Brain Edema

fludarabine has been researched along with Brain Edema in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Bejar, J; Garty-Ofir, M; Kreiniz, N; Polliack, A; Tadmor, T1
Hey, SP; Kesselheim, AS1
Hawkes, N1
Fabiano, AJ; Fenstermaker, RA; Qiu, J; Rigual, D1

Trials

1 trial(s) available for fludarabine and Brain Edema

ArticleYear
Trial of novel leukaemia drug is stopped for second time after two more deaths.
    BMJ (Clinical research ed.), 2016, Nov-25, Volume: 355

    Topics: Antineoplastic Agents; Brain Edema; Early Termination of Clinical Trials; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; United States; United States Food and Drug Administration; Vidarabine

2016

Other Studies

3 other study(ies) available for fludarabine and Brain Edema

ArticleYear
Demyelinating brain lesions developing in a patient with chronic lymphocytic leukemia shortly after treatment with a fludarabine containing regimen.
    Hematological oncology, 2021, Volume: 39, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Edema; Cyclophosphamide; Demyelinating Diseases; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Rituximab; Steroids; Vidarabine

2021
The FDA, Juno Therapeutics, and the ethical imperative of transparency.
    BMJ (Clinical research ed.), 2016, Aug-15, Volume: 354

    Topics: Brain Edema; Clinical Trials, Phase II as Topic; Disclosure; Drug Industry; Drugs, Investigational; Humans; Immunotherapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Safety-Based Drug Withdrawals; United States; United States Food and Drug Administration; Vidarabine

2016
Tumoral Bing-Neel Syndrome presenting as a cerebellar mass.
    Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:6

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Brain Edema; Cerebellar Neoplasms; Cyclophosphamide; Dexamethasone; Doxorubicin; Fatal Outcome; Humans; Lenalidomide; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Nervous System Diseases; Neurosurgical Procedures; Prednisone; Rituximab; Thalidomide; Treatment Outcome; Vidarabine; Vincristine; Waldenstrom Macroglobulinemia

2013